Cargando…

Immune Checkpoint Inhibitor Therapy Associated Hypophysitis

Ipilimumab is a monoclonal antibody directed against CTLA4 T-lymphocyte antigen used as cancer therapy. Immune-related adverse events are common side effects and may include hypophysitis-related hypopituitarism. The clinical features of six patients with ipilimumab-induced hypophysitis (IH) are desc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahzari, Moeber, Liu, Dora, Arnaout, Amel, Lochnan, Heather
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376202/ https://www.ncbi.nlm.nih.gov/pubmed/25861234 http://dx.doi.org/10.4137/CMED.S22469

Ejemplares similares

Ipilimumab (Immune Checkpoint Inhibitors) Hypophysitis
por: Stagnetto, Margot, et al.
Publicado: (2020)

Progress and Challenges of Immune Checkpoint Inhibitor-Induced Hypophysitis
por: Chen, Piaohong, et al.
Publicado: (2023)

Acute TSH stimulation in vivo does not alter serum PCSK9 levels
por: Gagnon, AnneMarie, et al.
Publicado: (2014)

Recurrence of Hypophysitis After Immune Checkpoint Inhibitor Rechallenge
por: Park, Benjamin C, et al.
Publicado: (2022)

Characterizing Immune Checkpoint Inhibitor-Induced Hypophysitis and Obstacles in Diagnosis
por: Johnson, Jake, et al.
Publicado: (2021)

Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population
por: Wei, Khor Zhong, et al.
Publicado: (2019)

SUN-298 Spectrum of Imaging in Immune Checkpoint Inhibitor Induced Hypophysitis
por: Quandt, Zoe, et al.
Publicado: (2020)

Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns
por: Nguyen, Ha, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function
por: Jessel, Shlomit, et al.
Publicado: (2022)

Early Detection of Immune-Mediated Hypophysitis With Use of Checkpoint Inhibitor Immunotherapy
por: Yossef, Kristena, et al.
Publicado: (2022)

Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors
por: Fujita, Yasunori, et al.
Publicado: (2023)

A Case of Abdominal Pain and Diarrhea Post Immunotherapy: Hypophysitis Associated with Immune Checkpoint Inhibitors
por: Alok, Akankcha, et al.
Publicado: (2022)

Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis
por: Thapi, Sahityasri, et al.
Publicado: (2019)

MON-LB029 The Influence of SGLT-2 Inhibitors and Other Glucose-Lowering Therapies on All-Cause Mortality Risk and Cardiovascular Outcomes in Older Patients with Newly Treated Type 2 Diabetes: A Population-Based Cohort Study
por: Doyle, Mary-Anne, et al.
Publicado: (2019)

Homozygous Familial Hypercholesterolemia (HoFH) in Saudi Arabia and Two Cases of Lomitapide Use in a Real-World Setting
por: Mahzari, Moeber, et al.
Publicado: (2021)

Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome
por: Kanie, Keitaro, et al.
Publicado: (2021)

LBODP071 Early Detection Of Immune-mediated Hypophysitis With Use Of Checkpoint Inhibitor Immunotherapy
por: Lai, William, et al.
Publicado: (2022)

OR32-02 Immune Checkpoint Inhibitor-Induced Hypophysitis Is Associated with Improved Overall Survival in Cancer Patients
por: Kotwal, Anupam, et al.
Publicado: (2020)

SUN-417 Recovery Of Central Adrenal Insufficiency In A Patient With Hypophysitis Secondary To Immune Checkpoint Inhibitors Therapy
por: Thapi, Sahityasri, et al.
Publicado: (2019)

Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists
por: Druce, Irena, et al.
Publicado: (2022)

MON-370 Isolated Secondary Adrenal Insufficiency in the Absence of Hypophysitis Secondary to Immune Checkpoint Inhibitors
por: Lu, Mary, et al.
Publicado: (2019)

Immune Checkpoint Inhibitor-Induced Hypophysitis in Renal Cell Carcinoma: Two Contrasting Case Presentations
por: Okigbo, Chinelo, et al.
Publicado: (2021)

Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor–Induced Hypophysitis
por: Quandt, Zoe, et al.
Publicado: (2023)

Sitosterolemia: A Case Report and a Concise Literature Review
por: Mahzari, Moeber M.
Publicado: (2023)

THU092 Characterizing Immune Checkpoint Inhibitor Induced Hypophysitis In A Large Urban Health Care System
por: Gogerly-Moragoda, Mahalya, et al.
Publicado: (2023)

SAT327 A Curious Case of Immune Checkpoint Inhibitor Induced Hypophysitis with Transient ACTH-dependent Hypercortisolism
por: Shi, Meng Zhu, et al.
Publicado: (2023)

PMON18 A Case of Hypophysitis and Hyperthyroidism Following COVID-19 Vaccine in a Patient Receiving Immune-Checkpoint Inhibitor Therapy
por: Gunapalan, Tharini, et al.
Publicado: (2022)

Stuck at the Checkpoint: Pembrolizumab Induced Hypophysitis With ‘Normal’ Cosyntropin Response
por: Kasiri, Elnaz, et al.
Publicado: (2021)

Immune checkpoint inhibitors in cancer therapy
por: Webb, Eika S., et al.
Publicado: (2018)

Immune Checkpoint Inhibitors in Cancer Therapy
por: Shiravand, Yavar, et al.
Publicado: (2022)

Adherence therapy for adults with type 2 diabetes: a feasibility study of a randomized controlled trial
por: Alenazi, Fatimah, et al.
Publicado: (2023)

A study protocol for a feasibility trial of telephone‐delivered Adherence Therapy for adults with type 2 diabetes
por: Alenazi, Fatimah, et al.
Publicado: (2021)

PMON49 Checkpoint Inhibitor Induced Hypophysitis with Growth Hormone Deficiency and Implications for the Treatment of ACTH Deficiency
por: DeCherney, Stephen, et al.
Publicado: (2022)

Molecular and Genetic Immune Biomarkers of Primary and Immune-Therapy Induced Hypophysitis: From Laboratories to the Clinical Practice
por: Chiloiro, Sabrina, et al.
Publicado: (2021)

Hypophysitis: Evaluation and Management
por: Faje, Alexander
Publicado: (2016)

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
por: Lee, Juwon, et al.
Publicado: (2021)

The Role of Immune Checkpoint Inhibitors in Cancer Therapy
por: Basudan, Ahmed M.
Publicado: (2022)

FRI238 A Rare Combination Of Thyroiditis And Secondary Adrenal Insufficiency Likely Secondary To Hypophysitis In A Patient Treated With Immune Checkpoint Inhibitors
por: Patel, Shivani, et al.
Publicado: (2023)

Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy
por: Rajha, Eva, et al.
Publicado: (2019)

Clinical Characteristics and Outcomes in Immune Checkpoint Inhibitor Therapy-Associated Myocarditis
por: Thakker, Ravi A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vjdqeiosdqci3ud81vfcrb2bpf